X 
Board Meetings
Home | Market Info | Company Profile | Board Meetings
Arihant Superstructures Ltd.
BSE CODE: 506194   |   NSE CODE: ARIHANTSUP   |   ISIN CODE : INE643K01018   |   21-Nov-2024 Hrs IST
BSE NSE
Rs. 338.60
-10.75 ( -3.08% )
 
Prev Close ( Rs.)
349.35
Open ( Rs.)
340.50
 
High ( Rs.)
343.65
Low ( Rs.)
333.30
 
Volume
3440
Week Avg.Volume
4870
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 335.95
-12.15 ( -3.49% )
 
Prev Close ( Rs.)
348.10
Open ( Rs.)
346.00
 
High ( Rs.)
346.00
Low ( Rs.)
333.00
 
Volume
10127
Week Avg.Volume
44913
 
52 WK High-Low Range(Rs.)
240.1
434.95
Source DateBoard Meeting DateDetails
18-Oct-2024 26-Oct-2024 Quarterly Results
01-Aug-2024 09-Aug-2024 Quarterly Results
09-May-2024 15-May-2024 Quarterly Results & Final Dividend & Audited Results
20-Mar-2024 23-Mar-2024 Inter alia, to consider and approve: - To consider and approve fund raising by way issue of securities including securities and warrants convertible into non convertible debt instruments Subject to approval of Board of Directors and approvals from the other regulatory authorities as may be required
16-Feb-2024 24-Feb-2024 Inter alia, to consider the following proposal: - 1) To take note of the performance evaluation of the Independent Directors for the financial year 2023-24 2) To consider and discuss the appointment of Ms. Tasneem Marfatia as company secretary and compliance officer of the company. 3) To take note of the terms of appointment of the Directors and Key Managerial Personnel and evaluation of increase / decrease in remuneration as per the performance evaluation submitted and taken on table by the board. 4) To consider any other matter with the permission of the Chair.
02-Feb-2024 12-Feb-2024 Quarterly Results
31-Oct-2023 07-Nov-2023 Quarterly Results & Inter alia, to consider:- b) To consider and approve the appointment of Chairman of Audit and Nomination & Remuneration Committee c) To consider and approve fund raising by way of issue of share warrants or any other securities through private placement/preferential issue or through any other permissible mode and/ or combination thereof as may be considered appropriate subject to approval from the shareholders and approvals from the other regulatory authorities as may be required.
04-Aug-2023 11-Aug-2023 Quarterly Results (Revised)
31-Jul-2023 10-Aug-2023 A.G.M. & Quarterly Results
22-May-2023 22-May-2023 Quarterly Results(Cancelled)
Page 1 of 12
PREV || NEXT